Audrey Greenberg is Chair of Business Development and a Venture Partner at Mayo Clinic. She has raised more than $1.5 billion in capital and built multiple category-defining ventures, including the Center for Breakthrough Medicines, acquired by SK pharmteco. She brings deep expertise in biotech, manufacturing, and finance, serving on boards across healthcare, biotechnology, real estate and economic development.